Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
InnoVein
company
About
InnoVein is revolutionizing vein care with an implantable valve.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.37M
- Industries
- Impact Investing,Medical,Natural Resources
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
InnoVein is a venture backed medical device company. Its technology is focused on cardiac and arterial approaches. The company develops and offers an implantable valve that can regularizes blood flow in the veins of elderly people suffering from venous insufficiency disease. InnoVein was founded in 2015 and is headquartered in San Carlos, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.59M
InnoVein has raised a total of
$1.59M
in funding over 2 rounds. Their latest funding was raised on
Sep 19, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 19, 2019 | Grant | $1.37M | 1 |
National Science Foundation
|
— | Detail |
| Jul 12, 2017 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
InnoVein is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
